UTHealth receives supplemental grant to establish Biosafety and Infectious Disease Training Initiative

Researchers from The University of Texas Health Science Center at Houston (UTHealth) School of Public Health have received a $100,000 supplemental grant from the National Institute of Environmental Health Sciences (NIEHS) to establish a Biosafety and Infectious Disease Training Initiative.

"We learned firsthand from the recent Ebola experience in Texas that concerns about infectious disease exposures extend far beyond the health care community," said Robert Emery, Dr. P.H., professor in the Department of Epidemiology, Human Genetics and Environmental Sciences at UTHealth School of Public Health and vice president of safety, health, environment and risk management at UTHealth.

"This award will allow us to develop and deliver meaningful training to a wide variety of audiences, including workers who we don't usually consider at risk for exposure to the Ebola virus, such as public service employees, waste handlers, funeral directors and others," Emery added.

UTHealth will partner with the Nebraska Biocontainment Unit, one of only three biocontainment units in the country, to establish this new training program. The program will include an intensive hands-on operations-level course, an awareness-level course and a community-level course to be delivered online.

"Personnel will deliver this training using a train-the-trainer model to amplify the impact of the award," said Janelle Rios, Ph.D., deputy director of the Southwest Center for Occupational and Environmental Health at the School of Public Health. "In the future, we intend to develop refresher training as well."

This grant is a supplement of a larger project called the Hazardous Materials Worker Health and Safety Training, funded by NIEHS Award Number U45ES019360. The original five-year grant was for $4 million and began in 2010.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Pfizer-BioNTech vaccine provides strong protection against MIS-C in children aged 5–17